CLINICAL TRIALS PROFILE FOR MESNEX
✉ Email this page to a colleague
All Clinical Trials for MESNEX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002804 ↗ | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1996-09-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, surgery, and radiation therapy in treating children who have advanced soft tissue sarcoma. |
| NCT00002804 ↗ | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | Completed | Children's Oncology Group | Phase 2 | 1996-09-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, surgery, and radiation therapy in treating children who have advanced soft tissue sarcoma. |
| NCT00002816 ↗ | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | Completed | National Cancer Institute (NCI) | Phase 3 | 1996-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in treating children who have relapsed acute lymphoblastic leukemia. |
| NCT00002816 ↗ | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | Completed | Children's Oncology Group | Phase 3 | 1996-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in treating children who have relapsed acute lymphoblastic leukemia. |
| NCT00002829 ↗ | Bone Marrow Transplantation in Treating Patients With Lymphoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1994-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells, and may be an effective treatment for lymphoma. Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill cancer cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients with recurrent or residual low-grade lymphoma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MESNEX
Condition Name
Clinical Trial Locations for MESNEX
Trials by Country
Clinical Trial Progress for MESNEX
Clinical Trial Phase
Clinical Trial Sponsors for MESNEX
Sponsor Name
